SCHEMBL6071635

SCHEMBL6071635

CN(C)Cn1ccnn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24725732 0.79 CYP19A1 (0.36)
SCHEMBL10605553 0.77 CYP19A1 (0.38)
SCHEMBL10065550 0.77 HTR1A (0.40)
SCHEMBL27633913 0.74 FOLH1 (0.36)
SCHEMBL10090899 0.74 HTR1A (0.38)
SCHEMBL251196 0.72
SCHEMBL10602777 0.72 DNM1 (0.36)
SCHEMBL10600908 0.71 CYP19A1 (0.35)
SCHEMBL11361006 0.71 CYP19A1 (0.48)
SCHEMBL10424811 0.71 CYP19A1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0160620-B1 METAL DEACTIVATORS CIBA-GEIGY AG (CH) 1989-09-13 EP claimed
US-20060264460-A1 3-Cyanoquinoline inhibitors of Tpl2 kinase and methods of making and using the same WYETH (US) 2006-11-23 US disclosed